Ballantyne CM - Search Results

1

Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death.

Jia X, Al Rifai M, Hoogeveen R, Echouffo-Tcheugui JB, Shah AM, Ndumele CE, Virani SS, Bozkurt B, Selvin E, Ballantyne CM, Nambi V. Jia X, et al. Among authors: ballantyne cm. JAMA Cardiol. 2023 Mar 1;8(3):222-230. doi: 10.1001/jamacardio.2022.5309. JAMA Cardiol. 2023. PMID: 36753229 Free PMC article.

2

Effects of cyclosporine therapy on plasma lipoprotein levels.

Ballantyne CM, Podet EJ, Patsch WP, Harati Y, Appel V, Gotto AM Jr, Young JB. Ballantyne CM, et al. JAMA. 1989 Jul 7;262(1):53-6. JAMA. 1989. PMID: 2733125 Clinical Trial.

3

Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients.

Hoogeveen RC, Ballantyne CM, Pownall HJ, Opekun AR, Hachey DL, Jaffe JS, Oppermann S, Kahan BD, Morrisett JD. Hoogeveen RC, et al. Among authors: ballantyne cm. Transplantation. 2001 Oct 15;72(7):1244-50. doi: 10.1097/00007890-200110150-00011. Transplantation. 2001. PMID: 11602850

4

Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.

Morrisett JD, Abdel-Fattah G, Hoogeveen R, Mitchell E, Ballantyne CM, Pownall HJ, Opekun AR, Jaffe JS, Oppermann S, Kahan BD. Morrisett JD, et al. Among authors: ballantyne cm. J Lipid Res. 2002 Aug;43(8):1170-80. J Lipid Res. 2002. PMID: 12177161 Free article.

5

Leptin and incident type 2 diabetes: risk or protection?

Schmidt MI, Duncan BB, Vigo A, Pankow JS, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G; ARIC Investigators. Schmidt MI, et al. Among authors: ballantyne cm. Diabetologia. 2006 Sep;49(9):2086-96. doi: 10.1007/s00125-006-0351-z. Epub 2006 Jul 19. Diabetologia. 2006. PMID: 16850292

6

Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study.

Hoogeveen RC, Ballantyne CM, Bang H, Heiss G, Duncan BB, Folsom AR, Pankow JS. Hoogeveen RC, et al. Among authors: ballantyne cm. Diabetologia. 2007 Jan;50(1):36-42. doi: 10.1007/s00125-006-0533-8. Epub 2006 Nov 29. Diabetologia. 2007. PMID: 17136392

7

How to identify patients with vulnerable plaques.

Virani SS, Ballantyne CM. Virani SS, et al. Among authors: ballantyne cm. Diabetes Obes Metab. 2008 Sep;10(10):824-33. doi: 10.1111/j.1463-1326.2007.00812.x. Epub 2007 Oct 29. Diabetes Obes Metab. 2008. PMID: 17970757 Review.

8

Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study.

Ballantyne CM, Hoogeveen RC, McNeill AM, Heiss G, Schmidt MI, Duncan BB, Pankow JS. Ballantyne CM, et al. Int J Obes (Lond). 2008 May;32 Suppl 2(Suppl 2):S21-4. doi: 10.1038/ijo.2008.31. Int J Obes (Lond). 2008. PMID: 18469836 Free PMC article.

9

Preoperative statin therapy decreases risk of postoperative renal insufficiency.

Virani SS, Nambi V, Polsani VR, Lee VV, Elayda M, Kohsaka S, Pan W, Reul RM, Wilson JM, Petersen LA, Willerson JT, Ballantyne CM. Virani SS, et al. Among authors: ballantyne cm. Cardiovasc Ther. 2010 Apr;28(2):80-6. doi: 10.1111/j.1755-5922.2009.00124.x. Cardiovasc Ther. 2010. PMID: 20398096 Free article.

10

Therapy and clinical trials: HDL-cholesterol and niacin therapy--past, present, and future.

Virani SS, Ballantyne CM. Virani SS, et al. Among authors: ballantyne cm. Curr Opin Lipidol. 2010 Apr;21(2):165-6. doi: 10.1097/MOL.0b013e32833768fd. Curr Opin Lipidol. 2010. PMID: 20616632 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,022 results

Search Page